Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lixiang Education ADR | LXEH | Mar 27, 2024 | 0.44 | +2.54 |
Lixte Biotechnology | LIXT | Mar 27, 2024 | 3.52 | +56.10 |
LKQ | LKQ | Mar 27, 2024 | 53.15 | +1.98 |
LL Flooring | LL | Mar 27, 2024 | 1.80 | +1.12 |
Lloyds Banking ADR | LYG | Mar 27, 2024 | 2.63 | +1.94 |
LM Funding America | LMFA | Mar 27, 2024 | 3.20 | +11.11 |
LMP Capital And Income Fund | SCD | Mar 27, 2024 | 15.45 | +0.72 |
LoanDepot A | LDI | Mar 27, 2024 | 2.57 | +7.08 |
Lobo EV Technologies | LOBO | Mar 27, 2024 | 3.09 | 0.00 |
Locafy | LCFY | Mar 27, 2024 | 5.05 | +2.96 |
Local Bounti | LOCL | Mar 27, 2024 | 2.92 | +1.73 |
Lockheed Martin | LMT | Mar 27, 2024 | 456.78 | +2.42 |
Loews | L | Mar 27, 2024 | 78.10 | +1.57 |
Logan Ridge Finance | LRFC | Mar 27, 2024 | 22.70 | +0.75 |
LogicMark | LGMK | Mar 27, 2024 | 1.00 | -0.01 |
Logitech International SA | LOGI | Mar 27, 2024 | 88.46 | -2.53 |
Loma Negra Compania Industrial Argentina Sociedad Anonima AD | LOMA | Mar 27, 2024 | 6.82 | -1.30 |
Loncar Cancer Immunotherapy ETF | CNCR | Mar 27, 2024 | 16.45 | +4.11 |
Long-Term Bond Index ETF Vanguard | BLV | Mar 27, 2024 | 72.36 | +0.92 |
Long-Term Corp Bond Idx ETF Vanguard | VCLT | Mar 27, 2024 | 78.20 | +0.96 |
Long-Term Govt Bond Idx ETF Vanguard | VGLT | Mar 27, 2024 | 59.25 | +0.82 |
Longboard Pharmaceuticals | LBPH | Mar 27, 2024 | 20.98 | +4.33 |
Longeveron | LGVN | Mar 27, 2024 | 3.11 | +804.86 |
Loop Industries | LOOP | Mar 27, 2024 | 2.75 | -1.79 |
Loop Media | LPTV | Mar 27, 2024 | 0.35 | +0.37 |
Lottery.com | LTRY | Mar 27, 2024 | 2.06 | +2.49 |
Lotus Technology | LOT | Mar 27, 2024 | 6.35 | 0.00 |
Louisiana-Pacific | LPX | Mar 27, 2024 | 83.60 | +1.51 |
Lovesac | LOVE | Mar 27, 2024 | 22.39 | +3.47 |
Lowes | LOW | Mar 27, 2024 | 253.33 | +0.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.